Northern New Jersey Community Clinical Oncology Program
新泽西州北部社区临床肿瘤学计划
基本信息
- 批准号:6760201
- 负责人:
- 金额:$ 31.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-09-01 至 2007-05-31
- 项目状态:已结题
- 来源:
- 关键词:antineoplastic antibioticsantineoplasticsarsenicbehavioral /social science research tagblood /lymphatic neoplasmbone neoplasmsbrain neoplasmsbreast neoplasmscancer preventioncancer registry /resourcecancer rehabilitation /carechemopreventionclinical researchcommunity health servicescooperative studycytokinedata managementdeferoxamineexperimental designsgastrointestinal neoplasmshealth services research taghuman subjecthuman therapy evaluationkidney neoplasmslarynx neoplasmsliver neoplasmslung neoplasmsmedical outreach /case findingmedical rehabilitation related tagmelanomamonoclonal antibodyneoplasm /cancer chemotherapyneoplasm /cancer diagnosisneoplasm /cancer educationneoplasm /cancer epidemiologyneoplasm /cancer immunotherapyneoplasm /cancer radiation therapyneoplasm /cancer surgeryneoplasm /cancer therapyneoplasm /cancer vaccinenutrition aspect of cancerpatient oriented researchpediatric neoplasm /cancerprostate neoplasmsretinoateseleniumstem cell transplantationthalidomidetocopherols
项目摘要
DESCRIPTION (provided by applicant): The Northern New Jersey CCOP (NNJCCOP)
provides access to clinical trials for cancer treatment and cancer control to
almost half of the 8.4 million population of New Jersey, as well as adjacent
New York and Pennsylvania. Forty-three physicians have access to trials,
including pediatric and adult hematology/oncologists, surgeons, urologists,
radiation oncologists, gynecologic oncologists and urologists. 37 Additional
physicians are actively involved in the work of the CCOP. Extensive outreach
ensures broad physician referral for cancer control. They are supported by a
well-trained cadre of research nurses, pharmacists and data managers. The
CCOP has created an effective and experienced infrastructure to ensure
compliance with the highest standards of clinical research. The physicians
build on a long tradition of closely-knit integration at the three clinical
sites at two component hospitals. Hackensack University Medical Center (HUMC)
includes a pediatric program, Tomorrows Children?s Institute (TCI) and an
adult program, the Northern New Jersey Cancer Center (NNJCC). Trinitas
Hospital, a component hospital resides in Union County, serving a high
minority population. The two hospitals are primary sources of oncology care
in their catchment areas and together accrue more than 2400 new cancer
patients each year. The specific aims of the program are to: reduce cancer
incidence, morbidity and mortality through expansion of clinical trials;
develop creative and innovative means of communication, collaboration and
education among physicians, health providers and citizens to accelerate cancer
prevention, detection and treatment; ensure broader participation in trials
among minority and female participants; and assure high standards of
excellence and quality in cancer trials. Strong leadership, an effective
organizational structure and proven track record support the goals of
accelerated outreach, broad recruitment, expanded accrual, effective followup,
accurate data management, compliance with quality assurance standards and
active participation in the design, and implementation of new clinical trials.
For the grant period, 2002-2007, the NNJCCOP projects accrual of 1482 adult
credits (420 treatment and 1062 cancer control and follow-up) and 318.2
pediatric credits with 298 treatments and 20.2 cancer control credits. This
represents a combined 5-year projected accrual of 1800.2 credits.
描述(由申请人提供):新泽西州北部 CCOP (NNJCCOP)
提供参与癌症治疗和癌症控制临床试验的机会
新泽西州以及邻近地区 840 万人口的近一半
纽约和宾夕法尼亚州。四十三名医生有机会参加试验,
包括儿科和成人血液科/肿瘤科医师、外科医生、泌尿科医师、
放射肿瘤科医生、妇科肿瘤科医生和泌尿科医生。 37 附加
医生们积极参与CCOP的工作。广泛的外展活动
确保广泛的医生转诊以控制癌症。他们得到了支持
训练有素的研究护士、药剂师和数据管理员骨干队伍。这
CCOP 创建了有效且经验丰富的基础设施,以确保
符合临床研究的最高标准。医生们
建立在三个临床领域紧密结合的悠久传统之上
两个组成医院的站点。哈肯萨克大学医学中心 (HUMC)
包括儿科项目、明天儿童研究所 (TCI) 和
成人计划,新泽西州北部癌症中心 (NNJCC)。三位一体
医院是一家附属医院,位于联合县,为高收入人群提供服务
少数民族人口。两家医院是肿瘤治疗的主要来源
在他们的集水区总共增加了 2400 多个新癌症
每年都有患者。该计划的具体目标是: 减少癌症
通过扩大临床试验来降低发病率、发病率和死亡率;
开发创造性和创新性的沟通、协作和
对医生、卫生服务提供者和公民进行教育以加速癌症发生
预防、检测和治疗;确保更广泛地参与试验
少数族裔和女性参与者;并保证高标准
癌症试验的卓越性和质量。强有力的领导,有效的
组织结构和良好的业绩记录支持目标
加速外展、广泛招募、扩大应计项目、有效后续行动,
准确的数据管理,符合质量保证标准和
积极参与新临床试验的设计和实施。
在 2002 年至 2007 年的赠款期内,NNJCCOP 预计将增加 1482 名成人
学分(420 治疗和 1062 癌症控制和随访)和 318.2
儿科学分,包括 298 个治疗和 20.2 个癌症控制学分。这
预计 5 年合计应计 1800.2 学分。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD J ROSENBLUTH其他文献
RICHARD J ROSENBLUTH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD J ROSENBLUTH', 18)}}的其他基金
NORTHERN NEW JERSEY COMMUNITY CLINICAL ONCOLOGY PROGRAM
新泽西州北部社区临床肿瘤学计划
- 批准号:
2088826 - 财政年份:1983
- 资助金额:
$ 31.06万 - 项目类别:
NORTHERN NEW JERSEY COMMUNITY CLINICAL ONCOLOGY PROGRAM
新泽西州北部社区临床肿瘤学计划
- 批准号:
2088825 - 财政年份:1983
- 资助金额:
$ 31.06万 - 项目类别:
BERGEN-PASSAIC COMMUNITY CLINICAL ONCOLOGY PROGRAM
BERGEN-PASSAIC 社区临床肿瘤学计划
- 批准号:
3557474 - 财政年份:1983
- 资助金额:
$ 31.06万 - 项目类别:
Northern New Jersey Community Clinical Oncology Program
新泽西州北部社区临床肿瘤学计划
- 批准号:
6659829 - 财政年份:1983
- 资助金额:
$ 31.06万 - 项目类别:
相似海外基金
Fetal arsenic-nutrient interaction in adult-onset cancer
成人发病癌症中胎儿砷与营养素的相互作用
- 批准号:
7039311 - 财政年份:2006
- 资助金额:
$ 31.06万 - 项目类别:
Arsenic Trioxide in Primary Curative APL Therapy
三氧化二砷在 APL 初级治疗中的应用
- 批准号:
7086337 - 财政年份:2004
- 资助金额:
$ 31.06万 - 项目类别:
Arsenic Trioxide in Primary Curative APL Therapy
三氧化二砷在 APL 初级治疗中的应用
- 批准号:
6824591 - 财政年份:2004
- 资助金额:
$ 31.06万 - 项目类别:
Arsenic Trioxide in Primary Curative APL Therapy
三氧化二砷在 APL 初级治疗中的应用
- 批准号:
6936029 - 财政年份:2004
- 资助金额:
$ 31.06万 - 项目类别:
Elimination of Chemotherapy in Newly-Diagnosed APL
新诊断 APL 患者无需化疗
- 批准号:
6646916 - 财政年份:2003
- 资助金额:
$ 31.06万 - 项目类别:
Arsenic Trioxide Down-Regulates STAT3 Activity in AML
三氧化二砷下调 AML 中的 STAT3 活性
- 批准号:
6648141 - 财政年份:2003
- 资助金额:
$ 31.06万 - 项目类别:
Elimination of Chemotherapy in Newly-Diagnosed APL
新诊断 APL 患者无需化疗
- 批准号:
6751997 - 财政年份:2003
- 资助金额:
$ 31.06万 - 项目类别:
Arsenic Trioxide Down-Regulates STAT3 Activity in AML
三氧化二砷下调 AML 中的 STAT3 活性
- 批准号:
6749587 - 财政年份:2003
- 资助金额:
$ 31.06万 - 项目类别: